GlassScriptPhysician profile
Lisa Hwang
NPI 1134449382
$2,718.57
in general payments reported to CMS, 2019-2025
11 companies · $1,172 in 2025
The $1,172 reported for 2025 was more than what 89% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $16.49 · 2021: $341 · 2022: $344 · 2023: $350 · 2024: $494 · 2025: $1,172.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,240 · Long Term Medical Supply Or Device Loan: $776.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,240.42 |
| Long Term Medical Supply Or Device Loan | $776.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $841.85 | 2025 | Durasorb Monofilament Mesh, Integra, Integra Dermal Regeneration Template |
| Tela Bio, INC. | $530.05 | 2022-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Bard Peripheral Vascular, INC. | $302.95 | 2021 | |
| Motiva USA, LLC | $284.95 | 2024-2025 | |
| Galderma Laboratories, L.P. | $174.24 | 2020-2023 | |
| Mentor Worldwide LLC | $163.79 | 2024 | Mentor Memorygel Resterilizable Gel Sizer |
| Davol INC. | $137.44 | 2025 | Galaflex |
| Abbvie INC. | $115.89 | 2024 | |
| Sun Pharmaceutical Industries INC. | $96.02 | 2023-2025 | Cequa |
| Merz North America, INC. | $39.18 | 2023-2024 | Xeomin |
| Pacira Pharmaceuticals Incorporated | $32.21 | 2021-2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Hwang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.